Anti-inflammatory drugs inhibit degradation of equine synovial fluid induced by free radicals.
Auer
D E
DE
School of Veterinary Science, University of Queensland.
Ng
J C
JC
Reilly
J S
JS
Seawright
A A
AA
D000818:Animals; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005609:Free Radicals; D006734:Horse Diseases / Q000188:drug therapy* / Q000378:metabolism; D006736:Horses; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D015203:Reproducibility of Results; D012980:Sodium Salicylate / Q000494:pharmacology / Q000627:therapeutic use; D013582:Synovial Fluid / Q000187:drug effects* / Q000378:metabolism; D013585:Synovitis / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary*; D014783:Viscosity
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005609:Free Radicals; D010653:Phenylbutazone; D001241:Aspirin; D012980:Sodium Salicylate; D004121:Dimethyl Sulfoxide